FULGENT THERAPEUTICS LLC

Fulgent Therapeutics LLC specializes in advanced molecular diagnostics and genomic sequencing services for federal health programs, with deep expertise in germline genetic testing, pharmacogenomics, and SARS-CoV-2 genomic analysis. The company delivers high-complexity clinical laboratory services using next-generation sequencing platforms such as Illumina HiSeq, enabling precision medicine applications through variant detection, haplotype analysis, and molecular biomarker identification. Their technical capabilities span molecular assay development, bioinformatics pipeline validation, and regulatory-compliant reporting for clinical decision support, with a demonstrated focus on hereditary disease risk assessment and drug response profiling. Differentiators include rapid turnaround for high-volume genomic testing and adherence to CLIA and CAP standards in a clinical laboratory setting. The contractor maintains a consistent relationship with the Department of Veterans Affairs, providing targeted genetic testing services to support veteran healthcare personalization, including pharmacogenomic guidance for chronic pain and psychiatric medication management. They also deliver genomic sequencing support to the Department of Health and Human Services, particularly for public health surveillance and infectious disease monitoring, indicating a strong alignment with federal biomedical research and population health initiatives. Fulgent Therapeutics operates primarily under NAICS 621511 (Medical Laboratories), focusing on clinical-grade genetic and molecular diagnostics, with supplementary experience in pharmaceutical preparation manufacturing for genetic testing reagents and testing laboratory services for genomic data generation. Their market positioning is centered on precision diagnostics for federal healthcare systems, bridging clinical genomics with operational scalability in government settings. As a small business structured as a 2K entity based in El Monte, California, Fulgent Therapeutics lacks federal certifications but maintains a focused presence in the federal life sciences market through specialized, high-compliance laboratory operations. Their geographic footprint supports direct service delivery to VA medical centers and HHS research partners across the western United States.